-
Collaboration to support value-based reimbursement models for GLP-1 receptor agonists, optimizing patient outcomes, increasing markets, and healthcare sustainability.
Nov 24, 2025
-
Nov 19, 2025
-
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness
Nov 17, 2025
-
CluePoints, provider of leading statistical and AI-driven software solutions, has announced Sylviane de Viron, its Data and Knowledge Manager, has been appointed to the Applied Clinical Trials (ACT) editorial advisory board.
Nov 10, 2025
-
• Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins
• Broadens Amperia’s applications across recombinant protein research, screening, and development
• Abselion to showcase kit alongside Amperia platform at PEGS Europe in Lisbon, Portugal from 11–13 November
Nov 9, 2025
-
Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it was awarded a multi-year national contract from the United States Department of Veterans Affairs (VA) to deliver pharmacogenomic (PGx) testing and germline genetic testing services, which includes hereditary cancer testing to veterans across the VA healthcare system.
Nov 9, 2025
-
As of Nov. 1, 2025, Medi-Cal (California’s Medicaid) has begun covering whole genome sequencing (WGS). This landmark coverage expands access to WGS for patients across California.
Nov 2, 2025
-
Nov 2, 2025
-
• Offers UK academic research institutions improved access to Primerdesign’s real-time PCR assays and reagents with reliable, fast and local support
• SLS to showcase Primerdesign portfolio at Lab Innovations in Birmingham, UK (29–30 October)
Oct 29, 2025
-
EazeBio has announced a strategic partnership with the University of California, Santa Cruz to advance and commercialize a groundbreaking instrument-free diagnostic platform.
Oct 28, 2025
-
Spaarne Gasthuis, a top clinical teaching hospital serving part of the Greater Amsterdam region, is fully digitizing its pathology practice with Concentriq® AP-Dx* from Proscia®. With this software platform, the hospital will empower its pathologists to play an even more significant role in guiding personalized treatment decisions for hundreds of thousands of patients each year.
Oct 26, 2025
-
Molsid, a French biotech company, announces the successful completion of the clinical performance study for ResiScreen® Staph, an innovantive solution for faster detection of staphylococcal beta-lactamase. Powered by Molsid's patented SmartID® fluorescent biotracer technology, ResiScreen® Staph reaffirms the company's mission to deliver next-generation diagnostic technologies to support clinical laboratories in the contention of antimicrobial resistance.
Oct 26, 2025
-
Recognized for Global Precision Health Informatics Industry Excellence in Best Practices
Oct 21, 2025
-
Oct 21, 2025
-
Oct 20, 2025
-
Creative Diagnostics introduces a comprehensive suite of validated Inorganic Pyrophosphatase ELISA Kits for the research community.
Oct 18, 2025
-
STEMart announces the launch of its Bacterial Reverse Mutation Test (Ames) service.
Oct 18, 2025
-
Collaboration unites elluminate platform technology and ZS RBQM expertise to offer a fully integrated, data-driven approach to risk and quality management
Oct 15, 2025
-
Proscia®, a pathology AI company, will add AI biomarker detection for skin tissue to its Concentriq® software platform, empowering pathologists to drive efficiency and precision. Powered by Primaa, Cleo Skin* will strengthen Concentriq's lead in offering the industry’s broadest portfolio of AI solutions on a single platform.
Oct 14, 2025
-
Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting
Oct 14, 2025